2-methylellipticinium has been researched along with elliptinium in 7 studies
| Studies (2-methylellipticinium) | Trials (2-methylellipticinium) | Recent Studies (post-2010) (2-methylellipticinium) | Studies (elliptinium) | Trials (elliptinium) | Recent Studies (post-2010) (elliptinium) |
|---|---|---|---|---|---|
| 12 | 0 | 0 | 135 | 8 | 1 |
| Protein | Taxonomy | 2-methylellipticinium (IC50) | elliptinium (IC50) |
|---|---|---|---|
| Mast/stem cell growth factor receptor Kit | Homo sapiens (human) | 0.205 | |
| Platelet-derived growth factor receptor alpha | Homo sapiens (human) | 0.7 | |
| Fibroblast growth factor receptor 3 | Homo sapiens (human) | 0.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Auclair, C; Hyland, K; Paoletti, C | 1 |
| Auclair, C; Banoun, H; Bernadou, J; Meunier, B; Paoletti, C; Voisin, E | 1 |
| Auclair, C; Paoletti, C | 1 |
| Auclair, C; Dugue, B; Meunier, B | 1 |
| Brasseur, R; de Kruijff, B; Huart, P; Nicolay, K; Ruysschaert, JM; Sautereau, AM; Tocanne, JF | 1 |
| Sautereau, AM; Trombe, MC | 1 |
| Laneelle, G; Lempereur, L; Sautereau, AM; Tocanne, JF | 1 |
7 other study(ies) available for 2-methylellipticinium and elliptinium
| Article | Year |
|---|---|
Autoxidation of the antitumor drug 9-hydroxyellipticine and its derivatives.
Topics: Alkaloids; Chemical Phenomena; Chemistry; Edetic Acid; Ellipticines; Kinetics; Manganese; Oxidation-Reduction; Oxygen Consumption; Spectrophotometry; Structure-Activity Relationship; Superoxide Dismutase | 1983 |
Potential antitumor agents: synthesis and biological properties of aliphatic amino acid 9-hydroxyellipticinium derivatives.
Topics: Alkaloids; Amino Acids; Animals; Anti-Bacterial Agents; Antineoplastic Agents; Ellipticines; Intercalating Agents; Leukemia L1210; Mice; Solubility | 1984 |
Bioactivation of the antitumor drugs 9-hydroxyellipticine and derivatives by a peroxidase-hydrogen peroxide system.
Topics: Alkaloids; Animals; Antineoplastic Agents; Biotransformation; Ellipticines; Hydrogen Peroxide; Mice; Oxidation-Reduction; Peroxidases; Structure-Activity Relationship | 1981 |
Covalent binding of elliptinium acetate (NSC 264137) to nucleic acids of L1210 cells in culture.
Topics: Alkaloids; Alkylation; Animals; Antineoplastic Agents; Cells, Cultured; DNA; Ellipticines; Kinetics; Leukemia L1210; Mice; Nucleic Acids; Oxidation-Reduction; RNA; Structure-Activity Relationship; Tritium | 1986 |
A comparative model membrane study on structural effects of membrane-active positively charged anti-tumor drugs.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Antineoplastic Agents; Calcium; Calorimetry, Differential Scanning; Cardiolipins; Doxorubicin; Electrochemistry; Ellipticines; Epirubicin; Ethidium; Lipid Bilayers; Liposomes; Magnetic Resonance Spectroscopy; Membrane Potentials; Molecular Conformation; Phosphatidylethanolamines; Pressure; Surface Properties | 1988 |
Electric transmembrane potential mutation and resistance to the cationic and amphiphilic antitumoral drugs derived from pyridocarbazole, 2-N-methylellipticinium and 2-N-methyl-9-hydroxyellipticinium, in Streptococcus pneumoniae.
Topics: Alkaloids; Chemical Phenomena; Chemistry; Chromosome Mapping; Drug Resistance, Microbial; Ellipticines; Membrane Potentials; Mutation; Streptococcus pneumoniae | 1986 |
Ellipticine derivatives interacting with model membranes. Influence of quaternarization of nitrogen-2.
Topics: Alkaloids; Cations; Cell Membrane; Diffusion; Ellipticines; Liposomes; Phosphatidylglycerols; Spectrometry, Fluorescence; Structure-Activity Relationship | 1984 |